Human Primary Diabetic Tracheal Epithelial Cells
Quick Actions
Product Overview
Description
Human Primary Diabetic Tracheal Epithelial Cells are cryopreserved primary human epithelial cells intended for in vitro research on diabetes-associated cellular dysfunction. The product is supplied as an early-passage culture and is designed for mechanistic studies, disease modeling, assay development, and pharmacology. The scientific profile emphasizes preservation of tissue-relevant phenotype while minimizing passage-related drift.
Guarantee expansion for a minimum of 2-5 population
doublings.
IMPORTANT: Quality warranty requires use of NeoBioPharma media. Biohazardous material despite negative pathogen testing. Quality claims must be reported within 1 month.
Key Features
Catalog Number: NBPE007
Product Format: Frozen
Vial Cell Number: > 5x10[5] cells/vial
Passage:1(P1)
Storage: Liquid Nitrogen, Vapor Phase
Intended Use: Research use only (RUO)
Characterization Markers
Positive for endothelial markers: Positive for epithelial
markers: E-cadherin and/or ZO-1 (tight junction protein) by
immunofluorescence staining .
- Isolated using EpCAM-1 (CD326) antibody with magnetic beads
to ensure epithelial purity
Quick Facts
Product Type
Human Type II Diabetes Endothelial Cells
Viability
>95% viable (Trypan Blue exclusion)
Applications
Research & Development
Availability
In Stock • Global Shipping
Technical Specifications
Applications & Use Cases
Research Areas
In Vitro Studies
Cell culture and screening applications
Molecular Biology
Gene expression & signaling studies
Drug Discovery
Screening & validation studies
Disease Modeling
Pathophysiology research
Support & Resources
Technical Support
Our experts are available for technical questions and protocol assistance.
Contact Support
